Skip to the page

Data / Form D filings / Luxvitae Therapeutics Inc.

Luxvitae Therapeutics Inc.: Form D filing

Luxvitae Therapeutics Inc., a company in San Diego, CA, filed a Form D with the SEC in 2025. The latest, on January 29, 2025, reports $8.5 million sold of an offering with no set size to 28 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7084 MIRAMAR RD, SUITE 401, San Diego, CA, 92121
Phone
(858) 729-3339
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2052787

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 29, 2025New noticeIndefinite$8,500,00028Nov 21, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Xianzhong WuDirector
Zhengyuan WangDirector
Feng TianExecutive Officer, Director

Other companies in California that filed recently

Every Form D from the week of Jan 27, 2025 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Luxvitae Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.